ONTX - Onconova Therapeutics GAAP EPS of -$0.20 beats by $0.11 revenue of $0.06M misses by $0.01M August, 10 2023 04:26 PM Onconova Therapeutics Inc. 2023-08-10 16:26:07 ET Onconova Therapeutics press release ( NASDAQ: ONTX ): Q2 GAAP EPS of -$0.20 beats by $0.11 . Revenue of $0.06M (flat Y/Y) misses by $0.01M . For further details see: Onconova Therapeutics GAAP EPS of -$0.20 beats by $0.11, revenue of $0.06M misses by $0.01M